Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase 1/2b study of Ibrutinib with Carlfizomib with R/R Myeloma
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristina Gasparetto
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Pharmacyclics, Inc.
Start Date
January 20, 2013
End Date
September 15, 2021
Awarded By
Pharmacyclics, Inc.
Start Date
January 20, 2013
End Date
September 15, 2021
